Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor Metastatic Cancer Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Testing effectiveness (Phase 2)Ended earlyNCT04471415
What this trial is testing

Study to Investigate DRP-104 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung Cancer Metastatic
Dracen Pharmaceuticals, Inc. 61
Early research (Phase 1)Looking for participantsNCT06612840
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Active Not RecruitingNCT02453620
What this trial is testing

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+2 more
National Cancer Institute (NCI) 57
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Testing effectiveness (Phase 2)Study completedNCT03495882
What this trial is testing

Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)

Who this might be right for
Cervical Cancer
Agenus Inc. 175
Early research (Phase 1)UnknownNCT02650375
What this trial is testing

Study of Metatinib Tromethamine Tablet

Who this might be right for
Advanced or Metastatic Gastric CancerAdvanced or Metastatic Liver CancerAdvanced or Metastatic CRC+1 more
Jiangsu Simcere Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Ended earlyNCT05394675
What this trial is testing

DS-9606a in Patients With Advanced Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerGerm Cell Tumor
Daiichi Sankyo 88
Early research (Phase 1)UnknownNCT04987112
What this trial is testing

Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

Who this might be right for
Solid TumorCancer Metastatic
CanWell Pharma Inc. 36
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Early research (Phase 1)Study completedNCT01295827
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

Who this might be right for
Cancer, Solid Tumor
Merck Sharp & Dohme LLC 1,260
Early research (Phase 1)Study completedNCT00478725
What this trial is testing

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 10
Testing effectiveness (Phase 2)Looking for participantsNCT06060613
What this trial is testing

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Who this might be right for
Tumor SkinMetastatic MelanomaMelanoma+4 more
Obsidian Therapeutics, Inc. 208
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Early research (Phase 1)Study completedNCT04196283
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 30
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Early research (Phase 1)Study completedNCT04710043
What this trial is testing

Dose Escalation Trial of BNT152+153 in Patients With Cancer

Who this might be right for
Solid Tumor
BioNTech SE 86
Very early researchWithdrawnNCT03671720
What this trial is testing

Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden

Who this might be right for
Advanced CancerMetastatic Cancer
Capital Medical University
Testing effectiveness (Phase 2)Study completedNCT00248404
What this trial is testing

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)

Who this might be right for
Tumors
Kiadis Pharma 155
Next Page